Albany Molecular Renews Eli Lilly Partnership

Albany Molecular Research has renewed its drug discovery research agreement with Eli Lilly. Under the terms of the agreement, Albany, N.Y.-based Albany Molecular will provide fee-for-service chemistry research on projects in strategic therapeutic areas identified by Indianapolis-based Lilly. Financial details were not disclosed. The two companies have worked together since 1998.

The Business Review

(http://albany.bizjournals.com/albany/stories/2005/02/07/daily18.html)